Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults.

Gisev N, Hartikainen S, Chen TF, Korhonen M, Bell JS.

Int Psychogeriatr. 2012 Jul;24(7):1058-64. doi: 10.1017/S1041610212000117. Epub 2012 Feb 27.

PMID:
22364618
2.
3.

Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.

Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc JL, Vellas B, Andrieu S.

Curr Alzheimer Res. 2012 Nov;9(9):1106-16.

PMID:
22950915
4.

All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study.

Liperoti R, Onder G, Landi F, Lapane KL, Mor V, Bernabei R, Gambassi G.

J Clin Psychiatry. 2009 Oct;70(10):1340-7. doi: 10.4088/JCP.08m04597yel.

5.

Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.

Hollis J, Grayson D, Forrester L, Brodaty H, Touyz S, Cumming R.

Am J Geriatr Psychiatry. 2007 Nov;15(11):932-41.

PMID:
17974865
6.

Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.

Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas JA, Schneeweiss S.

BMJ. 2012 Feb 23;344:e977. doi: 10.1136/bmj.e977.

7.

Adverse events in elderly users of antipsychotic pharmacotherapy in the province of Manitoba: a retrospective cohort study.

Vasilyeva I, Biscontri RG, Enns MW, Metge CJ, Alessi-Severini S.

J Clin Psychopharmacol. 2013 Feb;33(1):24-30. doi: 10.1097/JCP.0b013e31827934a4.

PMID:
23277238
8.

Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.

Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbæk G.

Am J Geriatr Psychiatry. 2014 Apr;22(4):321-31. doi: 10.1016/j.jagp.2013.06.007. Epub 2013 Sep 7.

PMID:
24016844
9.

Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.

Mehta S, Johnson ML, Chen H, Aparasu RR.

J Clin Psychiatry. 2010 Jun;71(6):689-98. doi: 10.4088/JCP.09m05817yel.

PMID:
20573328
10.

Antipsychotic drug use and mortality in older adults with dementia.

Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA.

Ann Intern Med. 2007 Jun 5;146(11):775-86.

PMID:
17548409
11.

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J.

Lancet. 2009 Aug 22;374(9690):620-7. doi: 10.1016/S0140-6736(09)60742-X.

PMID:
19595447
12.

Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Alzheimers Dis. 2017;56(1):107-118. doi: 10.3233/JAD-160671.

PMID:
27935554
13.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
14.

Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.

Laitinen ML, Bell JS, Lavikainen P, Lönnroos E, Sulkava R, Hartikainen S.

Int Psychogeriatr. 2011 Dec;23(10):1623-31. doi: 10.1017/S1041610211001621. Epub 2011 Aug 26.

PMID:
21867581
15.

Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.

Rafaniello C, Lombardo F, Ferrajolo C, Sportiello L, Parretta E, Formica R, Potenza S, Rinaldi B, Irpino A, Raschetti R, Vanacore N, Rossi F, Capuano A.

Eur J Clin Pharmacol. 2014 Feb;70(2):187-95. doi: 10.1007/s00228-013-1588-3. Epub 2013 Oct 22.

PMID:
24145814
16.

Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents.

Aparasu RR, Chatterjee S, Mehta S, Chen H.

Med Care. 2012 Nov;50(11):961-9. doi: 10.1097/MLR.0b013e31826ec185.

PMID:
23047786
17.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
18.

Antipsychotic use and myocardial infarction in older patients with treated dementia.

Pariente A, Fourrier-Réglat A, Ducruet T, Farrington P, Béland SG, Dartigues JF, Moore N, Moride Y.

Arch Intern Med. 2012 Apr 23;172(8):648-53; discussion 654-5. doi: 10.1001/archinternmed.2012.28. Epub 2012 Mar 26.

PMID:
22450214
19.

Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

J Alzheimers Dis. 2014;41(4):1223-8. doi: 10.3233/JAD-140282.

PMID:
24787914
20.

Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland.

Teramura-Grönblad M, Bell JS, Pöysti MM, Strandberg TE, Laurila JV, Tilvis RS, Soini H, Pitkälä KH.

J Am Med Dir Assoc. 2012 Jun;13(5):488.e9-13. doi: 10.1016/j.jamda.2012.03.003. Epub 2012 Apr 6.

PMID:
22483648

Supplemental Content

Support Center